A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee
Completed
Pfizer
Phase 3
2006-12-01
The purpose of this study is to evaluate the efficacy of Kadian NT (ALO-01) compared with
placebo for treating moderate to severe chronic pain over a 12 week period.
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions
Completed
Actavis Inc.
Phase 1
2004-08-01
The objective of this single-dose, open-label, randomized, two-period crossover study was to
compare the rate of absorption and oral bioavailability of a test formulation of morphine
sulfate 200 mg sustained-release capsules manufactured by Alpharma Branded Products Division
Inc. to an equivalent oral dose of the commercially available reference product, KADIAN 2 x
100 mg capsules manufactured by Alpharma Branded Products Division Inc. when administered
under fed conditions.
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions
Completed
Actavis Inc.
Phase 1
2004-09-01
The objective of this single-dose, open-label, randomized, two-period crossover study was to
compare the rate of absorption and oral bioavailability of a test formulation of morphine
sulfate 200 mg sustained-release capsules manufactured by Alpharma Branded Products Division
Inc. to an equivalent oral dose of the commercially available reference product, KADIAN 2 x
100 mg capsules manufactured by Alpharma Branded Products Division Inc. when administered
after a 10-hour overnight fast.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
